Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in<i>in vitro</i>and<i>in vivo</i>pharmacokinetic studies employing Bcrp1−/−/Mdr1a/1b−/− (triple-knockout) and wild-type mice
Serena Marchetti, Jan H.M. Schellens(Utrecht University), Olaf van Tellingen(Dutch Cancer Society), Jos H. Beijnen(The Netherlands Cancer Institute), Maria J. Bolijn, Tessa Buckle(Leiden University Medical Center), Roberto Mazzanti(Azienda Ospedaliero-Universitaria Careggi), Nienke A. de Vries(The Netherlands Cancer Institute), Maria A.J. van Eijndhoven
Cited by 200
Related Papers
Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer
|New England Journal of Medicine|2019|1.5k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884